Clinical Trial Update: The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab as consolidation therapy after definitive concurrent chemoradiotherapy for locally advanced thoracic esophageal squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Wuhan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED